Search the Archive

Medicine: Breast Cancer / Treatment #1137925

NBC Evening News for Saturday, Jun 01, 2019
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

(Virginia Beach: Jose Diaz Balart) Report introduced.

(New York: John Torres) Breaking news on a medical breakthrough in treating advanced breast cancer examined; details given about the collaboration between the UCLA Johnson Comprehensive Cancer Center & University of Texas MD Anderson Cancer Center on using the drug ribociclib with hormone therapy. [Cancer patient Bernadette MARTINHO-BREWER%- talks about living with cancer.] [UCLA Cancer Center breast cancer program dir. Dr. Sara HURVITZ@- talks about the results for longer survival.] The next step in treatment discussed.

Balart, Jose Diaz;
Torres, John

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.